Your browser doesn't support javascript.
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
Li, Zhe; Lin, Yuxi; Huang, Yi-You; Liu, Runduo; Zhan, Chang-Guo; Wang, Xin; Luo, Hai-Bin.
  • Li Z; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, 510006 Guangzhou, People's Republic of China.
  • Lin Y; Center for Innovative Marine Drug Screening & Evaluation, School of Medicine and Pharmacy, Ocean University of China, 266100 Qingdao, China.
  • Huang YY; School of Life Sciences, Lanzhou University, 734000 Lanzhou, China.
  • Liu R; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, 510006 Guangzhou, People's Republic of China.
  • Zhan CG; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, 510006 Guangzhou, People's Republic of China.
  • Wang X; Molecular Modeling and Biopharmaceutical Center, College of Pharmacy, University of Kentucky, Lexington, KY 40536; zhan@uky.edu wx8399@ouc.edu.cn luohb77@mail.sysu.edu.cn.
  • Luo HB; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536.
Proc Natl Acad Sci U S A ; 118(8)2021 02 23.
Article in English | MEDLINE | ID: covidwho-1324478
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oxytetracycline / COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oxytetracycline / COVID-19 Drug Treatment Limits: Humans Language: English Year: 2021 Document Type: Article